1. Juruena MF, Young AH, Hodsoll J, Lewis G, Veale D. Efficacy and safety of bright light therapy for bipolar depression. Psychiatry Clin. Neurosci. 2020; 74: 408–410. 2. Takeshima M, Utsumi T, Aoki Y et al. Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry Clin. Neurosci. 2020; 74: 247–256. 3. Tseng P-T, Chen Y-W, Tu K-Y et al. Light therapy in the treatment of patients with bipolar depression: A meta-analytic study. Eur. Neuropsychopharmacol. 2016; 26: 1037–1047. 4. Gottlieb JF, Benedetti F, Geoffroy PA et al. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD Task Force on Chronotherapy and Chronobiology. Bipolar Disord. 2019; 21: 741–773. 5. Yorguner Kupeli N, Bulut NS, Carkaxhiu Bulut G, Kurt E, Kora K. Efficacy of bright light therapy in bipolar depression. Psychiatry Res. 2018; 260: 432–438. 6. Zhou TH, Dang WM, Ma YT et al. Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial. J. Affect. Disord. 2018; 227: 90–96. 7. Sit DK, McGowan J, Wiltrout C et al. Adjunctive bright light therapy for bipolar depression: A randomized double-blind placebo-controlled trial. Am. J. Psychiatry 2018; 175: 131–139. 8. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: Replication of main effects and interaction. Psychiatry Res. 2000; 95: 43–53. 9. Franchini L, Ballan S, Colombo C, Smeraldi E. Light therapy and fluvoxamine in the treatment of bipolar psychotic depression: A pilot study. Clin. Neuropsychiatry 2009; 6: 166–173. 10. Dauphinais DR, Rosenthal JZ, Terman M, Difebo HM, Tuggle C, Rosenthal NE. Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression. Psychiatry Res. 2012; 196: 57–61.

中文翻译：

---

开发和验证日语版的维度冷漠量表（J-DAS）

1. Juruena MF、Young AH、Hodsoll J、Lewis G、Veale D。亮光疗法治疗双相抑郁症的疗效和安全性。精神病学临床。神经科学。2020 年；74：408-410。2. Takeshima M、Utsumi T、Aoki Y 等。强光疗法对双相障碍患者躁狂和抑郁症状的疗效和安全性：系统评价和荟萃分析。精神病学临床。神经科学。2020 年；74：247-256。3. Tseng PT、Chen YW、Tu KY 等。光疗法治疗双相抑郁症：一项荟萃分析研究。欧元。神经精神药理学。2016; 26：1037-1047。4. Gottlieb JF、Benedetti F、Geoffroy PA 等。双相情感障碍的时间疗法：来自 ISBD 时间疗法和时间生物学工作组的系统评价和实践建议。双相情感障碍。2019; 21: 741–773。5. Yorguner Kupeli N，Bulut NS、Carkaxhiu Bulut G、Kurt E、Kora K。亮光疗法对双相抑郁症的疗效。精神病学研究。2018 年；260：432–438。6. 周天、党卫明、马玉堂等。亮光疗法作为辅助疗法治疗急性双相抑郁症的临床疗效、起效时间和安全性：一项随机对照试验。J. 影响。紊乱。2018 年；227：90-96。7. Sit DK、McGowan J、Wiltrout C 等。双相抑郁的辅助强光疗法：一项随机双盲安慰剂对照试验。是。J. 精神病学 2018；175：131-139。8. Colombo C、Lucca A、Benedetti F、Barbini B、Campori E、Smeraldi E。完全睡眠剥夺联合锂和光疗法治疗双相抑郁症：主要效应和相互作用的复制。精神病学研究。2000；95：43-53。9. Franchini L、Ballan S、Colombo C、Smeraldi E。光疗法和氟伏沙明治疗双相精神病性抑郁症：一项初步研究。临床。神经精神病学 2009；6：166-173。10. Dauphinais DR、Rosenthal JZ、Terman M、Difebo HM、Tuggle C、Rosenthal NE。双相抑郁症患者强光治疗与空气负离子安全性和有效性的对照试验。精神病学研究。2012年；196：57-61。